AUROPHARMA Intraday Analysis...

AUROPHARMA Share Price

Open 1142.70 Change Price %
High 1216.80 1 Day 70.35 6.20
Low 1142.00 1 Week 46.05 3.97
Close 1205.10 1 Month 171.95 16.64
Volume 1523651 1 Year 681.55 130.18
52 Week High 1279.80
52 Week Low 503.40
AUROPHARMA Important Levels
Resistance 2 1274.44
Resistance 1 1245.87
Pivot 1187.97
Support 1 1164.33
Support 2 1135.76
AUROPHARMA CURRENT MONTH FUTURE
Close 1219.60
Contracts Traded 20624
Open Intrest 10408500
Change In O.I 120250
Lot Size 250
AUROPHARMA CURRENT MONTH OPTION
Most Active Call 1200
Most Active put 1150
Highest O.I Buildup Call 1200
Highest O.I Buildup Put 1150
Expiry Date 30-Apr-2015
AUROPHARMA ALL MONTHS OPTIONS
For All AUROPHARMA Options Click Here
NSE INDIA Most Active Stocks
NIFTY 8341.40 -0.01%
UNITECH 16.35 2.19%
SUZLON 26.75 1.71%
JPASSOCIAT 24.50 3.16%
CNXIT 11968.50 0.56%
SBIN 263.60 2.71%
ICICIBANK 314.55 2.14%
GMRINFRA 15.55 1.97%
IDEA 172.30 -4.57%
ITC 317.50 -1.52%
More..
NSE INDIA Top Gainers Stocks
SASKEN 217.95 19.95%
WINDMACHIN 20.50 19.53%
SRGINFOTEC 0.35 16.67%
ARROWTEX 27.00 16.13%
KECL 26.85 14.99%
MAGNUM 3.10 14.81%
BLBLIMITED 4.10 13.89%
MVL 0.45 12.50%
MVL 0.45 12.50%
SEPOWER 4.75 11.76%
More..
NSE INDIA Top Losers Stocks
ANTGRAPHIC 0.10 -33.33%
ATNINTER 0.20 -20.00%
EXCELINFO 15.50 -16.67%
TAINWALCHM 20.60 -13.45%
TULSI 3.05 -12.86%
TIJARIA 2.80 -12.50%
EASTSILK 1.50 -11.76%
ARIHANT 38.90 -11.39%
CREATIVEYE 2.85 -10.94%
BROADCAST 2.90 -10.77%
More..

Aurobindo Pharma Limited (NSE: AUROPHARMA)

AUROPHARMA Technical Analysis 4
As on 27th Mar 2015 AUROPHARMA Share Price closed @ 1205.10 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 908.70 & Buy for SHORT-TERM with Stoploss of 1136.93 we also expect STOCK to react on Following IMPORTANT LEVELS.
AUROPHARMA Target for March
1st Target up-side 1270.55
2nd Target up-side 1401.69
3rd Target up-side 1532.83
1st Target down-side 896.35
2nd Target down-side 765.21
3rd Target down-side 634.07
AUROPHARMA Synopsis Technicals View
50 Day EMA Close is Above EMA 50 (Short Term)
Bullish
100 Day EMA Close is Above EMA 100 (Mid Term) Bullish
200 Day EMA Close is Above EMA 200 (Long Term) Bullish
MACD (12 26 9) MACD Line is Grater Then SIGNAL Line Bullish
RSI (14) RSI is 68.32 Sideways
MFI (14) MFI is 54.52 Sideways
CCI (20) CCI is -13.16 Sideways
WILLIAM %R (14) William %R is -42.53 Sideways
ADX (14) ADX is Above 20 & +DI is Above -DI Up Trend
PSAR Stoploss For Long Buy 658.30
10 Day Avg Volume Traded 16.95 % More then 10 Day Average Volume
AUROPHARMA Other Details
Segment EQ
Market Capital 25150871552.00
Sector Pharmaceuticals
Industry
Offical website
AUROPHARMA Address
AUROPHARMA
N/A
AUROPHARMA Latest News
Interactive Technical Analysis Chart Aurobindo Pharma Limited ( AUROPHARMA NSE INDIA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Aurobindo Pharma Limited
AUROPHARMA Business Profile
Aurobindo Pharm is in the Pharmaceuticals sector. Founded in 1986 by Mr. P.V. Ramaprasad Reddy, Mr. K. Nityananda Reddy and a small group of highly committed professionals, Aurobindo Pharma was born off a vision. The company commenced operations in 1988-89 with a single unit manufacturing Semi-Synthetic Penicillin (SSP) at Pondicherry. Aurobindo Pharma became a public company in 1992 and listed its shares in the Indian stock exchanges in 1995. In addition to being the market leader in Semi-Synthetic Penicillins, it has a presence in key therapeutic segments such as neurosciences, cardiovascular, anti-retrovirals, anti-diabetics, gastroenterology and cephalosporins, among others. Aurobindo makes use of in-house R&D for rapid filing of patents, Drug Master Files (DMFs), Abbreviated New Drug Applications (ANDAs) and formulation dossiers across the world. Aurobindo Pharma is among the largest filers of DMFs and ANDAs from India. The current market capitalisation stands at Rs 8,284.96 crore.The company has reported a consolidated sales of Rs 1913.86 crore and a Net Profit of Rs 233.86 crore for the quarter ended Sep 2013. The company management includes K Ragunathan - Non Executive Chairman, K Nithyananda Reddy - Vice Chairman & Whole Time Dir, N Govindarajan - Managing Director, M Sivakumaran - Whole Time Director, M Madan Mohan Reddy - Whole Time Director, P V Ramprasad Reddy - Non Executive Director, P Sarath Chandra Reddy - Non Executive Director, M Sitarama Murthy - Non Executive Director, D Rajagopala Reddy - Non Executive Director, C Channa Reddy - Non Executive Director. It is listed on the BSE with a BSE Code of 524804 and the NSE with an NSE Code of AUROPHARMA. Its Registered office is at Plot No. 2, Maitrivihar,,Ameerpet Hyderabad,Andhra Pradesh - 500038.